Stryker Corporation (NYSE:SYK) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Stryker Corporation (NYSE:SYK - Get Free Report) have earned a consensus rating of "Moderate Buy" from the nineteen analysts that are currently covering the stock, Marketbeat reports. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $428.55.

Several equities research analysts have recently commented on the company. Sanford C. Bernstein set a $450.00 price target on Stryker in a research note on Monday, May 5th. Wall Street Zen lowered Stryker from a "buy" rating to a "hold" rating in a research note on Friday, June 27th. JMP Securities reaffirmed a "market perform" rating on shares of Stryker in a research note on Monday, May 5th. Evercore ISI increased their price target on Stryker from $390.00 to $415.00 and gave the stock an "outperform" rating in a research note on Tuesday, July 8th. Finally, Needham & Company LLC reissued a "buy" rating and set a $442.00 price target on shares of Stryker in a research note on Friday, March 21st.

Insider Activity at Stryker

In other news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the transaction, the director owned 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. This trade represents a 5.53% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 5.90% of the company's stock.

Hedge Funds Weigh In On Stryker

Several large investors have recently modified their holdings of SYK. Elefante Mark B acquired a new stake in shares of Stryker in the fourth quarter valued at approximately $337,000. Mogy Joel R Investment Counsel Inc. increased its stake in shares of Stryker by 3.4% in the first quarter. Mogy Joel R Investment Counsel Inc. now owns 98,216 shares of the medical technology company's stock valued at $36,561,000 after purchasing an additional 3,218 shares during the period. Ferguson Wellman Capital Management Inc. increased its stake in shares of Stryker by 1.9% in the first quarter. Ferguson Wellman Capital Management Inc. now owns 174,871 shares of the medical technology company's stock valued at $65,096,000 after purchasing an additional 3,341 shares during the period. Harbor Capital Advisors Inc. acquired a new stake in shares of Stryker in the first quarter valued at approximately $1,840,000. Finally, Mar Vista Investment Partners LLC increased its stake in shares of Stryker by 10.2% in the first quarter. Mar Vista Investment Partners LLC now owns 90,187 shares of the medical technology company's stock valued at $33,572,000 after purchasing an additional 8,353 shares during the period. Institutional investors own 77.09% of the company's stock.

Stryker Stock Performance

NYSE SYK traded down $1.85 on Thursday, hitting $389.02. 1,039,855 shares of the company's stock were exchanged, compared to its average volume of 1,352,169. The firm's 50-day moving average price is $385.38 and its two-hundred day moving average price is $377.55. The firm has a market cap of $148.49 billion, a price-to-earnings ratio of 52.57, a P/E/G ratio of 2.95 and a beta of 0.91. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.64 and a quick ratio of 1.00. Stryker has a fifty-two week low of $314.93 and a fifty-two week high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, topping the consensus estimate of $2.73 by $0.11. The business had revenue of $5.87 billion for the quarter, compared to analyst estimates of $5.68 billion. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The company's quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.50 EPS. On average, research analysts expect that Stryker will post 13.47 EPS for the current year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.86%. Stryker's payout ratio is 45.41%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.